In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 37 for your search:
Cancer Type/Condition:  ductal breast carcinoma in situ
Stage/Subtype:  ductal breast carcinoma in situ
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 70
Sponsor: NIGMS
Protocol IDs: 0412-14, UO1-GM61373-06, NCT00228956

2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 45 and over
Sponsor: Other
Protocol IDs: Mammosite ML, NCT01448447

3.

Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P0334, NCT01501487

4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTPR-0009, NCT01644669

5.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00702, CDR0000615085, NSABP-B-43, U10CA012027, NCT00769379

7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 2009-APBI, WIRB #20091193, NCT01185132

8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1005, NCI-2011-02669, CDR0000700069, NCT01349322

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: S12-01299, NCT01591811

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644921, UPCC-15107, 807010, NCT00923143

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Adult
Sponsor: Other
Protocol IDs: 2008NTLS083, UMN-0809M45461, UMN-2008NTLS083, NCT01009437

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IFHCC 09-002, NCT01023477

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 41 and over
Sponsor: Other
Protocol IDs: 12-001 Single Fraction IORT, NCT01688388

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DCIS-WHM-703M, NCT00669747

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000675211, P30CA022453, WSU-2010-056, 2010-056, NCT01147016

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0818, NCI-2011-01102, NCT01245712

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: OSR #5110026, NCT01310530

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000701992, CALGB-40903, NCT01439711

19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: R10-00641, BC097854, NCT01372618

20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00050068, WCI1937-10, NCT01498588

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: I 108907, NCI-2009-01568, P30CA016056, NCT01754519

22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: BRE007-12, NCT01766297

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764

24.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-351, NCT01581619

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00875, 2008-0086, CDR0000573719, H-19895, P50-CA-58183, P50CA058183, P30CA016672, MDA-P50-CA-58183, BCM-H-19895, BCM-P50-CA-58183, NCT00555152
1   
New Search